MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 4,055.00
+55.00 (1.38%)
May 21, 2026, 11:09 AM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 137.1 billion as of May 20, 2026. Its market cap has increased by 25.79% in one year.
Market Cap
137.10B
Enterprise Value
100.93B
Revenue
3.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,055.00
Market Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 137.10B, a decrease of -62.18%. That is a compound annual growth rate of -14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 141.38B | -38.25% |
| Dec 30, 2025 | 228.96B | 50.62% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1.20T | -49.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 235.91B |
| EASY BIO,Inc. | 227.60B |
| JETEMA, | 210.23B |
| Genexine | 198.52B |
| Macrogen | 157.85B |
| Vaxcell-Bio Therapeutics | 149.31B |
| ENCell | 130.59B |
| Amicogen | 120.26B |